Stem Cell Therapeutic and Research Reauthorization Act of 2025

Hozzl · 2026-06-02T13:02:50Z

Explore the details of House Bill 5160 Stem Cell Therapeutic and Research Reauthorization Act of 2025 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

6/2/2026, 1:02 PM

Summary of Bill HR 5160

The bill H.R. 5160, introduced in the 119th Congress on September 4, 2025, aims to reauthorize the Stem Cell Therapeutic and Research Act of 2005 and includes provisions for other purposes, with specific directives and actions outlined in the bill text.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5160

Bill HR 5160 is currently in the status of Bill Introduced since September 4, 2025. Bill HR 5160 was introduced during Congress 119 and was introduced to the House on September 4, 2025. Bill HR 5160's most recent activity was Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0. as of May 21, 2026

Bipartisan Support of Bill HR 5160

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5160

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 5160

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.

Comments

Ayra McKenna

824

9 months ago

I don't think this bill is good idea. It could have big impact on stem cell research and therapy. It may not be good for people who need these treatments. I think it needs more discussion and thought before passing it. This bill could affect many people in a negative way. I hope they reconsider it.